These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

285 related items for PubMed ID: 11529935

  • 1. Interleukin-10 expressed at early tumour sites induces subsequent generation of CD4(+) T-regulatory cells and systemic collapse of antitumour immunity.
    Seo N, Hayakawa S, Takigawa M, Tokura Y.
    Immunology; 2001 Aug; 103(4):449-57. PubMed ID: 11529935
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-10 promotes B16-melanoma growth by inhibition of macrophage functions and induction of tumour and vascular cell proliferation.
    García-Hernández ML, Hernández-Pando R, Gariglio P, Berumen J.
    Immunology; 2002 Feb; 105(2):231-43. PubMed ID: 11872099
    [Abstract] [Full Text] [Related]

  • 3. Depletion of IL-10- and TGF-beta-producing regulatory gamma delta T cells by administering a daunomycin-conjugated specific monoclonal antibody in early tumor lesions augments the activity of CTLs and NK cells.
    Seo N, Tokura Y, Takigawa M, Egawa K.
    J Immunol; 1999 Jul 01; 163(1):242-9. PubMed ID: 10384122
    [Abstract] [Full Text] [Related]

  • 4. Downregulation of innate and acquired antitumor immunity by bystander gammadelta and alphabeta T lymphocytes with Th2 or Tr1 cytokine profiles.
    Seo N, Tokura Y.
    J Interferon Cytokine Res; 1999 Jun 01; 19(6):555-61. PubMed ID: 10433355
    [Abstract] [Full Text] [Related]

  • 5. Elimination of CD4(+) T cells enhances anti-tumor effect of locally secreted interleukin-12 on B16 mouse melanoma and induces vitiligo-like coat color alteration.
    Nagai H, Hara I, Horikawa T, Oka M, Kamidono S, Ichihashi M.
    J Invest Dermatol; 2000 Dec 01; 115(6):1059-64. PubMed ID: 11121142
    [Abstract] [Full Text] [Related]

  • 6. Down-regulation of tumoricidal NK and NK T cell activities by MHC Kb molecules expressed on Th2-type gammadelta T and alphabeta T cells coinfiltrating in early B16 melanoma lesions.
    Seo N, Tokura Y, Furukawa F, Takigawa M.
    J Immunol; 1998 Oct 15; 161(8):4138-45. PubMed ID: 9780186
    [Abstract] [Full Text] [Related]

  • 7. Tumour-derived IL-10 within tumour microenvironment represses the antitumour immunity of Socs1-silenced and sustained antigen expressing DCs.
    Song S, Wang Y, Wang J, Lian W, Liu S, Zhang Z, Liu F, Wei L.
    Eur J Cancer; 2012 Sep 15; 48(14):2252-9. PubMed ID: 22230748
    [Abstract] [Full Text] [Related]

  • 8. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
    Jarnicki AG, Lysaght J, Todryk S, Mills KH.
    J Immunol; 2006 Jul 15; 177(2):896-904. PubMed ID: 16818744
    [Abstract] [Full Text] [Related]

  • 9. CD4+ CD25+ transforming growth factor-beta-producing T cells are present in the lung in murine tuberculosis and may regulate the host inflammatory response.
    Mason CM, Porretta E, Zhang P, Nelson S.
    Clin Exp Immunol; 2007 Jun 15; 148(3):537-45. PubMed ID: 17362490
    [Abstract] [Full Text] [Related]

  • 10. Gene transfer of a hybrid interleukin-1 beta gene to B16 mouse melanoma recruits leucocyte subsets and reduces tumour growth in vivo.
    Björkdahl O, Wingren AG, Hedhund G, Ohlsson L, Dohlsten M.
    Cancer Immunol Immunother; 1997 Jul 15; 44(5):273-81. PubMed ID: 9247562
    [Abstract] [Full Text] [Related]

  • 11. Immunosuppressive activity of cloned natural killer (NK1.1+) T cells established from murine tumor-infiltrating lymphocytes.
    Tamada K, Harada M, Abe K, Li T, Tada H, Onoe Y, Nomoto K.
    J Immunol; 1997 May 15; 158(10):4846-54. PubMed ID: 9144500
    [Abstract] [Full Text] [Related]

  • 12. Transforming growth factor-beta (TGF-beta)-mediated immunosuppression in the tumor-bearing state: enhanced production of TGF-beta and a progressive increase in TGF-beta susceptibility of anti-tumor CD4+ T cell function.
    Li XF, Takiuchi H, Zou JP, Katagiri T, Yamamoto N, Nagata T, Ono S, Fujiwara H, Hamaoka T.
    Jpn J Cancer Res; 1993 Mar 15; 84(3):315-25. PubMed ID: 8098027
    [Abstract] [Full Text] [Related]

  • 13. Regulatory B1a Cells Suppress Melanoma Tumor Immunity via IL-10 Production and Inhibiting T Helper Type 1 Cytokine Production in Tumor-Infiltrating CD8+ T Cells.
    Kobayashi T, Oishi K, Okamura A, Maeda S, Komuro A, Hamaguchi Y, Fujimoto M, Takehara K, Matsushita T.
    J Invest Dermatol; 2019 Jul 15; 139(7):1535-1544.e1. PubMed ID: 30836062
    [Abstract] [Full Text] [Related]

  • 14. Induction by a lactic acid bacterium of a population of CD4(+) T cells with low proliferative capacity that produce transforming growth factor beta and interleukin-10.
    von der Weid T, Bulliard C, Schiffrin EJ.
    Clin Diagn Lab Immunol; 2001 Jul 15; 8(4):695-701. PubMed ID: 11427413
    [Abstract] [Full Text] [Related]

  • 15. The opposite effect of tumor-infiltrating natural killer cells on in vivo priming of tumor-specific CD8+ T cells and CD4+ T cells.
    Terao H, Harada M, Kurosawa S, Shinomiya Y, Ito O, Tamada K, Takenoyama M, Nomoto K.
    Immunobiology; 1996 Jul 15; 195(2):172-86. PubMed ID: 8877394
    [Abstract] [Full Text] [Related]

  • 16. A comparative study between T regulatory type 1 and CD4+CD25+ T cells in the control of inflammation.
    Foussat A, Cottrez F, Brun V, Fournier N, Breittmayer JP, Groux H.
    J Immunol; 2003 Nov 15; 171(10):5018-26. PubMed ID: 14607898
    [Abstract] [Full Text] [Related]

  • 17. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells.
    Weiner HL.
    Immunol Rev; 2001 Aug 15; 182():207-14. PubMed ID: 11722636
    [Abstract] [Full Text] [Related]

  • 18. Epicutaneous immunization induces alphabeta T-cell receptor CD4 CD8 double-positive non-specific suppressor T cells that inhibit contact sensitivity via transforming growth factor-beta.
    Szczepanik M, Bryniarski K, Tutaj M, Ptak M, Skrzeczynska J, Askenase PW, Ptak W.
    Immunology; 2005 May 15; 115(1):42-54. PubMed ID: 15819696
    [Abstract] [Full Text] [Related]

  • 19. The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens.
    Litton MJ, Dohlsten M, Rosendahl A, Ohlsson L, Søgaard M, Andersson J, Andersson U.
    Br J Cancer; 1999 Sep 15; 81(2):359-66. PubMed ID: 10496366
    [Abstract] [Full Text] [Related]

  • 20. CD25+, interleukin-10-producing CD4+ T cells are required for suppressor cell production and immune privilege in the anterior chamber of the eye.
    Skelsey ME, Mayhew E, Niederkorn JY.
    Immunology; 2003 Sep 15; 110(1):18-29. PubMed ID: 12941137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.